Skip to main content
. 2024 Jul 26;20(20):1385–1392. doi: 10.1080/14796694.2024.2351352

Figure 3.

Figure 3.

Overall survival in evaluable patients. *No. of patients at risk: month 0, n = 110; month 12, n = 54; month 24, n = 24; month 36, n = 11; month 48, n = 5; month 60, n = 2; month 70, n = 0.